Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125792293 | 12579229 | 3 | F | 20160826 | 20160721 | 20160907 | EXP | GB-009507513-1607GBR000703 | GB-CIPLA LTD.-2016GB09742 | CIPLA | 0.00 | Y | 0.00000 | 20160907 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125792293 | 12579229 | 1 | PS | Epirubicin | EPIRUBICIN | 1 | Unknown | UNK | U | U | 65361 | ||||||||
125792293 | 12579229 | 2 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | UNK | U | U | 0 | ||||||||
125792293 | 12579229 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
125792293 | 12579229 | 4 | SS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK | U | U | 0 | ||||||||
125792293 | 12579229 | 5 | SS | APREPITANT. | APREPITANT | 1 | Oral | UNK | U | U | 0 | CAPSULE | |||||||
125792293 | 12579229 | 6 | SS | APREPITANT. | APREPITANT | 1 | Unknown | UNK | U | U | 0 | CAPSULE | |||||||
125792293 | 12579229 | 7 | SS | DEXAMETHASONE SODIUM PHOSPHATE. | DEXAMETHASONE SODIUM PHOSPHATE | 1 | Oral | UNK | U | U | 0 | TABLET | |||||||
125792293 | 12579229 | 8 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
125792293 | 12579229 | 9 | SS | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125792293 | 12579229 | 1 | Product used for unknown indication |
125792293 | 12579229 | 2 | Product used for unknown indication |
125792293 | 12579229 | 3 | Product used for unknown indication |
125792293 | 12579229 | 4 | Product used for unknown indication |
125792293 | 12579229 | 5 | Product used for unknown indication |
125792293 | 12579229 | 7 | Product used for unknown indication |
125792293 | 12579229 | 8 | Product used for unknown indication |
125792293 | 12579229 | 9 | Prophylaxis of nausea and vomiting |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125792293 | 12579229 | OT |
125792293 | 12579229 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125792293 | 12579229 | Alopecia | |
125792293 | 12579229 | Asthenia | |
125792293 | 12579229 | Diarrhoea | |
125792293 | 12579229 | Fracture reduction | |
125792293 | 12579229 | Gastric disorder | |
125792293 | 12579229 | Gastroenteritis | |
125792293 | 12579229 | Injection site mass | |
125792293 | 12579229 | Injection site reaction | |
125792293 | 12579229 | Nausea | |
125792293 | 12579229 | Neutropenia | |
125792293 | 12579229 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |